Cargando…
Incidence of uveitis and macular edema among patients taking fingolimod 0.5 mg for multiple sclerosis
BACKGROUND: Patients with multiple sclerosis (MS) have a higher incidence of uveitis compared with the general population. Fingolimod, a first line disease modifying drug used in multiple sclerosis, may cause macular edema and thus requires ophthalmic examination. However, murine models and anecdota...
Autores principales: | Sonne, Scott Joseph, Smith, Bradley Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502642/ https://www.ncbi.nlm.nih.gov/pubmed/32954456 http://dx.doi.org/10.1186/s12348-020-00215-1 |
Ejemplares similares
-
Fingolimod-Associated Macular Edema in the Treatment of Multiple Sclerosis
por: Khan, Asma A, et al.
Publicado: (2023) -
Acute Anterior Uveitis in a Patient Taking Fingolimod (FTY720) for Multiple Sclerosis
por: Mack, Heather Gwen, et al.
Publicado: (2016) -
Acute onset of fingolimod-associated macular edema
por: Soliman, Mohamed Kamel, et al.
Publicado: (2016) -
Diagnosis and Management of Fingolimod-Associated Macular Edema
por: Wang, Chunjiang, et al.
Publicado: (2022) -
Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report
por: Akiyama, Hisanao, et al.
Publicado: (2016)